| # | Drug | Count |
|---|---|---|
| 0 | LANSOPRAZOLE | 20 |
| 1 | ADALIMUMAB | 17 |
| 2 | OMEPRAZOLE MAGNESIUM | 14 |
| 3 | PREDNISONE | 14 |
| 4 | MYCOPHENOLATE MOFETIL | 10 |
| 5 | TACROLIMUS | 10 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 9 |
| 7 | OMEPRAZOLE | 9 |
| 8 | PANTOPRAZOLE | 8 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUMASIRAN | 1 | 0.0026 |
| 1 | KETAMINE HYDROCHLORIDE | 4 | 0.0008 |
| 2 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 5 | 0.0006 |
| 3 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 4 | CICLOPIROX | 1 | 0.0004 |
| 5 | CHORIOGONADOTROPIN ALFA | 1 | 0.0004 |
| 6 | EVEROLIMUS TABLETS | 5 | 0.0003 |
| 7 | SILODOSIN | 1 | 0.0002 |
| 8 | BEVACIZUMAB-AWWB | 1 | 0.0002 |
| 9 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 1 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 2 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 9 | Anticholinergic [EPC] | 1 | 0.0001 |